122 related articles for article (PubMed ID: 26883473)
1. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs.
Ma M; Zhao L; Sun G; Zhang C; Liu L; Du Y; Yang X; Shan B
Oncol Rep; 2016 May; 35(5):3122-30. PubMed ID: 26883473
[TBL] [Abstract][Full Text] [Related]
2. Mda‑7/IL‑24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway.
Ma M; Yang X; Zhao L; Liu L; Zhang C; Wang X; Shan B
Mol Med Rep; 2017 Oct; 16(4):5633-5642. PubMed ID: 28849038
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells.
Cui Y; Yang F; He L
Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434
[TBL] [Abstract][Full Text] [Related]
4. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
6. Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.
Fang P; Zhang X; Gao Y; Ding CR; Cui F; Jiao SC
Anat Rec (Hoboken); 2012 Oct; 295(10):1639-46. PubMed ID: 22899557
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib enhances sensitivity to chemotherapy drugs of T-cell lymphoma.
Ma M; Yang X; Zhao L; Wang X; Liu L; Jiao W; Wei Y; Shan B
Oncol Lett; 2018 Apr; 15(4):4649-4656. PubMed ID: 29541237
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
9. TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
Ma X; Zhou X; Qu H; Ma Y; Yue Z; Shang W; Wang P; Xie S; Li Y; Sun Y
Oncol Rep; 2018 Apr; 39(4):1910-1918. PubMed ID: 29436678
[TBL] [Abstract][Full Text] [Related]
10. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
11. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
12. [Hyperactivation of c-Jun NH(2)-terminal protein kinase contributes to the proliferation of B lymphoma cells].
Guo YY; Cui J; Hou CM; Wang QY; Wang J; Ma YF; Zhang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):100-4. PubMed ID: 21362231
[TBL] [Abstract][Full Text] [Related]
13. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.
Gyémánt N; Tanaka M; Antus S; Hohmann J; Csuka O; Mándoky L; Molnár J
In Vivo; 2005; 19(2):367-74. PubMed ID: 15796199
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
[TBL] [Abstract][Full Text] [Related]
15. Is mda-7/IL-24 a potential target and biomarker for enhancing drug sensitivity in human glioma U87 cell line?
Wang Q; Zhu Y; Yang P
Anat Rec (Hoboken); 2013 Aug; 296(8):1154-60. PubMed ID: 23794295
[TBL] [Abstract][Full Text] [Related]
16. Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status.
Bracht K; Kiefer T; Dölken G; Bednarski PJ
J Cancer Res Clin Oncol; 2007 Dec; 133(12):957-67. PubMed ID: 17562080
[TBL] [Abstract][Full Text] [Related]
17. Reversal of cisplatin resistance in non-small cell lung cancer stem cells by Taxus chinensis var.
Jiang YQ; Xu XP; Guo QM; Xu XC; Liu QY; An SH; Xu JL; Su F; Tai JB
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706681
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
[TBL] [Abstract][Full Text] [Related]
19. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms].
Wu HJ; Wu HT; Weng DH; Xing H; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):612-6. PubMed ID: 17983517
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
